A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia

被引：1
|
作者：
Shah, Bijal D. [1 ]
Rozario, Nicole [2 ]
Turba, Elyce P. [3 ]
Bello, Celeste [4 ]
Chavez, Julio C. [3 ]
Sokol, Lubomir [4 ]
Brayer, Jason [5 ]
Lancet, Jeffrey E. [6 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-151936
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4399
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of venetoclax in combination with cytarabine and azacitidine (VAA) in relapsed/refractory acute myeloid leukemia: An open-label, single-arm, phase II study.
    You, Liangshun
    Liu, Yi
    Mai, Wenyuan
    Zhou, De
    Xie, Wanzhuo
    Mao, Liping
    Zhou, Xinping
    Tong, Hongyan
    Jin, Jie
    Meng, Haitao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study
    Peterlin, Pierre
    Le Bris, Yannick
    Turlure, Pascal
    Chevallier, Patrice
    Menard, Audrey
    Gourin, Marie-Pierre
    Dumas, Pierre-Yves
    Thepot, Sylvain
    Berceanu, Ana
    Park, Sophie
    Hospital, Marie -Anne
    Cluzeau, Thomas
    Bouzy, Simon
    Torregrosa-Diaz, Jose-Miguel
    Drevon, Louis
    Sapena, Rosa
    Chermat, Fatiha
    Ades, Lionel
    Dimicoli-Salazar, Sophie
    Chevret, Sylvie
    Bene, Marie-Christine
    Fenaux, Pierre
    LANCET HAEMATOLOGY, 2023, 10 (07): : E521 - E529
  • [23] Efficacy and safety blinatumomab in chinese adults with Ph-negative relapsed/refractory B-cell Precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study
    Zhou, Hongsheng
    Yin, Qingsong
    Jin, Jie
    Liu, Ting
    Cai, Zhen
    Jiang, Bin
    Li, Dengju
    Sun, Zimin
    Li, Yan
    He, Yanjuan
    Ma, Liping
    Gao, Sujun
    Hu, Jianda
    He, Aili
    Du, Xin
    Liu, Daihong
    Zhang, Xiaohong
    Ke, Xiaoyan
    Zhuang, Junling
    Han, Yue
    Wang, Xiaoqin
    Chen, Yuqi
    Gordon, Paul
    Yu, Dong
    Zugmaier, Gerhard
    Wang, Jianxiang
    HEMATOLOGY, 2022, 27 (01) : 917 - 927
  • [24] Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study
    Xu, Wei
    Zhou, Keshu
    Wang, Tingyu
    Yang, Shenmiao
    Liu, Lihong
    Hu, Yu
    Zhang, Wei
    Ding, Kaiyang
    Zhou, Jianfeng
    Gao, Sujun
    Xu, Bing
    Zhu, Zunmin
    Liu, Ting
    Zhang, Huilai
    Hu, Jianda
    Ji, Chunyan
    Wang, Shunqing
    Xia, Zhongjun
    Wang, Xin
    Li, Yan
    Song, Yongping
    Ma, Shuo
    Tang, Xinran
    Zhang, Bin
    Li, Jianyong
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 571 - 579
  • [25] Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenstrom's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study
    Cao, Xin-Xin
    Jin, Jie
    Fu, Cheng-Cheng
    Yi, Shu-Hua
    Zhao, Wei-Li
    Sun, Zi-Min
    Yang, Wei
    Li, Deng-Ju
    Cui, Guo-Hui
    Hu, Jian-da
    Liu, Ting
    Song, Yong-Ping
    Xu, Bing
    Zhu, Zun-Min
    Xu, Wei
    Zhang, Ming-Zhi
    Tian, Ya-Min
    Zhang, Bin
    Zhao, Ren-Bin
    Zhou, Dao-Bin
    ECLINICALMEDICINE, 2022, 52
  • [26] A phase II, open-label study of CLOFAREXTM in pediatric patients with refractory or relapsed acute-myelogenous or lymphoblastic leukemia
    Jeha, S
    Steinherz, P
    Altman, S
    Rheingold, S
    Gaynon, P
    Goldman, S
    Craig, A
    Weiss, J
    Arceci, R
    BLOOD, 2002, 100 (11) : 271B - 271B
  • [27] Apremilast for Discoid Lupus Erythematosus: Results of a Phase 2, Open-Label, Single-Arm, Pilot Study
    De Souza, Aieska
    Strober, Bruce E.
    Merola, Joseph F.
    Oliver, Stephen
    Franks, Andrew G., Jr.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (10) : 1224 - 1226
  • [28] A Phase II Study of CPX-351 Plus Venetoclax in Patients with Relapsed/Refractory (R/R) or Newly Diagnosed Acute Myeloid Leukemia (AML)
    Kim, Kunhwa
    Kantarjian, Hagop
    Borthakur, Gautam
    Takahashi, Koichi
    Short, Nicholas J.
    DiNardo, Courtney D.
    Jabbour, Elias J.
    Chien, Kelly S.
    Daver, Naval
    Pemmaraju, Naveen
    Jain, Nitin
    Adewale, Lade
    Montalban-Bravo, Guillermo
    Wierda, William G.
    Verstovsek, Srdan
    Konopleva, Marina
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2021, 138
  • [29] Everolimus (EVE) for relapsed/refractory classical Hodgkin lymphoma (cHL): Open-label, single-arm, phase II study.
    Johnston, Patrick B.
    Pinter-Brown, Lauren C.
    Rogerio, Jaqueline Willemann
    Warsi, Ghulam
    Chau, Quincy
    Ramchandren, Rod
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
    Harari, Sergio
    Elia, Davide
    Caminati, Antonella
    Geginat, Jens
    Luisi, Francesca
    Pelosi, Giuseppe
    Specchia, Claudia
    Torre, Olga
    Trevisan, Roberta
    Vasco, Chiara
    Zompatori, Maurizio
    Cassandro, Roberto
    LANCET RESPIRATORY MEDICINE, 2024, 12 (12): : 967 - 974
12345